|
Market Closed -
NYSE
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.3102 USD | -8.76% |
|
-11.27% | -93.93% |
| 08-28 | VolitionRx Files for Secondary Offering of Common Shares | MT |
| 08-14 | VolitionRx Limited, Q2 2026 Earnings Call, Aug 14, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VOLITIONRX LIMITED | Bio Diagnostics & Testing | -8.76% | -11.27% | -93.93% | -97.53% | -99.52% | 4.41M |  | | |
- Stock Market
- Stocks
- VNRX Stock
- Charts VolitionRx Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
